Safety and activity of IPI-504 (retaspimycin hydrochloride) and docetaxel in pretreated patients (pts) with metastatic non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Riely, G. J.; Gettinger, S. N.; Stoller, R. G.; Gabrail, N. Y.; Dy, G. K.; Weiss, G. J.; Tunkey, C.; Skliris, G.; Strychor, S.; Dunbar, J.; DeLucia, D.; Ross, R. W.; Gray, J. E. |
| Abstract Title: | Safety and activity of IPI-504 (retaspimycin hydrochloride) and docetaxel in pretreated patients (pts) with metastatic non-small cell lung cancer (NSCLC) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880302242 |
| DOI: | 10.1200/jco.2011.29.15_suppl.7516 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7516 -- Source: Wos |
